Cargando…

Human T‐lymphotropic virus in Irish blood donors: Impact on future testing strategy

AIM: A risk‐based approach to the testing of blood donations for Human T‐Lymphotropic Virus (HTLV) should include an assessment of blood donation seroepidemiology. The objectives of the present study were to determine the proportion of HTLV positive units in Irish blood donations, and subsequently,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Pádraig, O'Flaherty, Niamh, Field, Stephen, Waters, Allison
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Donor Infectious Disease Testing
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539962/ https://www.ncbi.nlm.nih.gov/pubmed/35829653 http://dx.doi.org/10.1111/trf.17017

Ejemplares similares

Prevalence of DNA of fourteen human polyomaviruses determined in blood donors
por: Kamminga, Sergio, et al.
Publicado: (2019)

Serologic screening of United States blood donors for Babesia microti using an investigational enzyme immunoassay
por: Levin, Andrew E., et al.
Publicado: (2016)

Detection of dengue, chikungunya, and Zika RNA in blood donors from Southeast Asia
por: Stanley, Jean, et al.
Publicado: (2020)

Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay
por: Levin, Andrew E, et al.
Publicado: (2014)

Trends and risk factors of SARS‐CoV‐2 infection in asymptomatic blood donors
por: Valenti, Luca, et al.
Publicado: (2021)

High prevalence of human T‐cell leukemia virus type‐1b genotype among blood donors in Gabon, Central Africa
por: Ramassamy, Jill‐Léa, et al.
Publicado: (2020)

Evidence of likely autochthonous Chagas disease in the southwestern United States: A case series of Trypanosoma cruzi seropositive blood donors
por: Lynn, Mary K., et al.
Publicado: (2022)

Duplex nucleic acid test for the detection of chikungunya and dengue RNA viruses in blood donations
por: Stramer, Susan L., et al.
Publicado: (2019)

Evaluation of a new West Nile virus nucleic acid test for screening of blood donations
por: Stanley, Jean, et al.
Publicado: (2018)

Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program
por: Wendel, Silvano, et al.
Publicado: (2020)

Detection of Babesia RNA and DNA in whole blood samples from US blood donations
por: Stanley, Jean, et al.
Publicado: (2021)

A WHO tool for risk‐based decision making on blood safety interventions
por: Janssen, Mart P., et al.
Publicado: (2020)

Economic implications of FDA platelet bacterial guidance compliance options: Comparison of single‐step strategies
por: Prioli, Katherine M., et al.
Publicado: (2022)

Assessment of Liaison XL Murex Chagas diagnostic performance in blood screening for Chagas disease using a reference array of chimeric antigens
por: Santos, Emily F., et al.
Publicado: (2021)

COVID‐19 antibody screening with SARS‐CoV‐2 red cell kodecytes using routine serologic diagnostic platforms
por: Nagappan, Radhika, et al.
Publicado: (2021)

Performance profile of an updated safety measure rapid assay for bacteria in platelets
por: Vallejo, Remo P., et al.
Publicado: (2020)

Longitudinal analysis of SARS‐CoV‐2 antibodies in 8000 U.S. first‐time convalescent plasma donations
por: Karbiener, Michael, et al.
Publicado: (2021)

A novel competition ELISA for the rapid quantification of SARS‐CoV‐2 neutralizing antibodies in convalescent plasma
por: Wouters, Elise, et al.
Publicado: (2021)

Evaluation of an improved rapid bacterial assay with untreated and pathogen‐reduced platelets: Detection of Acinetobacter strains
por: LaVerda, David, et al.
Publicado: (2021)

Acquired platelet storage container leaks and contamination with environmental bacteria: A preventable cause of bacterial sepsis
por: Gammon, Richard R., et al.
Publicado: (2021)

Confirmed circulation of SARS-CoV-2 in Irish blood donors prior to first national notification of infection
por: Butler, Dearbhla, et al.
Publicado: (2022)

The changing profile of SARS-CoV-2 serology in Irish blood donors
por: Coyne, Dermot, et al.
Publicado: (2023)

Donor and non‐donor perspectives on receiving information from routine genomic testing of donor blood
por: Thorpe, Rachel, et al.
Publicado: (2022)

Strongyloides stercoralis, Human T-cell Lymphotropic Virus Type-1 and Cytomegalovirus Coinfection in an Allogeneic Hematopoietic Stem-Cell Transplant Recipient
por: Rahman, Farah, et al.
Publicado: (2020)

Toxoplasmosis Immunity Status of Blood Donors in Sidi Bel Abbès, West Algeria
por: Belkacemi, Malika, et al.
Publicado: (2022)

Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections
por: Stewart, Zoe A., et al.
Publicado: (2021)

Deferral rate variability in blood donor eligibility assessment
por: de Kort, Wim, et al.
Publicado: (2018)

Incorporating apolipoprotein L1 testing into evaluation of potential living kidney donors: a single-centre experience
por: Dick, Jonathan, et al.
Publicado: (2019)

Do deferred donors continue their donations? A large‐scale register study on whole blood donor return in the Netherlands
por: Spekman, Marloes L.C., et al.
Publicado: (2019)

Risk of hematological malignancy in blood donors: A nationwide cohort study
por: Zhao, Jingcheng, et al.
Publicado: (2020)

Predicting Future Pandemics and Formulating Prevention Strategies: The Role of ChatGPT
por: Jana, Pradip K, et al.
Publicado: (2023)

Assessing the discrimination of the Kidney Donor Risk Index/Kidney Donor Profile Index scores for allograft failure and estimated glomerular filtration rate in Ireland’s National Kidney Transplant Programme
por: Sexton, Donal J, et al.
Publicado: (2019)

Effectiveness of Using Nucleic Acid Amplification Test to Screen Blood Donors for Hepatitis B, Hepatitis C, and HIV: A Tertiary Care Hospital Experience From Pakistan
por: Ali, Syeda M, et al.
Publicado: (2023)

First results of a ferritin‐based blood donor deferral policy in the Netherlands
por: Vinkenoog, Marieke, et al.
Publicado: (2020)

The healthy donor effect and survey participation, becoming a donor and donor career
por: Brodersen, Thorsten, et al.
Publicado: (2022)

Failure of self-disclosure of deferrable risk behaviors associated with transfusion-transmissible infections in blood donors
por: Wong, Horas Tze Hoo, et al.
Publicado: (2015)

Donor-derived Transmission of Hepatitis A Virus Following Kidney Transplantation: Clinical Course of Two Cases From One Donor
por: Jones, Jefferson M., et al.
Publicado: (2023)

Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies
por: Law, Arjun Datt, et al.
Publicado: (2018)

Whole blood donor behavior and availability after deferral: Consequences of a new ferritin monitoring policy
por: Spekman, Marloes L.C., et al.
Publicado: (2020)

Estimation of the number of blood donors during the COVID‐19 incubation period across China and analysis of prevention and control measures for blood transfusion transmission
por: Yuan, Zhaohu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oil1m5a0rs5drs6mjutmv9lb8k